- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone Receptor Negative Breast Cancer
Total 18059 results
-
Henrik DitzelNational Board of Health, Denmark; CytoVac A/SRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerDenmark
-
Massachusetts General HospitalMerck Sharp & Dohme LLCActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
University of PennsylvaniaCompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Kathy MillerCompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownMetastatic Breast CancerChina
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
UNICANCERGilead SciencesRecruitingMetastatic Breast Cancer | Triple Negative Breast CancerFrance
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Terminated
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
Fudan UniversityUnknownMetastatic Breast CancerChina
-
Xiang ZhangMirati Therapeutics Inc.TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
PfizerTerminatedNeoplasms | Triple-Negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
University of PennsylvaniaActive, not recruitingBreast Neoplasm | Metastatic Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
OncXerna Theraputics, Inc.RecruitingA Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid TumorsGastric Cancer | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast CancerUnited States
-
Providence Health & ServicesInhibrx, Inc.Not yet recruitingTriple Negative Breast CancerUnited States
-
University of ChicagoNot yet recruitingTriple Negative Breast Cancer
-
Assiut UniversityNot yet recruiting
-
Institut CurieRoche Pharma AG; National Research Agency, FranceNot yet recruitingTriple Negative Breast CancerFrance
-
Institut CurieHoffmann-La RocheRecruitingTriple Negative Breast CancerFrance
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi SankyoRecruitingBreast CancerUnited States, China, Denmark, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Belgium, Spain, Japan, France, Taiwan, Greece, Brazil, Sweden, Puerto Rico
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingTriple Negative Breast CancerChina
-
wang shusenRecruiting
-
Cantargia ABSpanish Breast Cancer Research GroupRecruitingTriple Negative Breast CancerSpain
-
Jewish General HospitalExactis InnovationRecruiting
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
Fudan UniversityRecruitingTriple Negative Breast CancerChina
-
Peking Union Medical College HospitalRecruitingTriple Negative Breast CancerChina
-
Shengjing HospitalRecruiting
-
Shengjing HospitalThe People's Hospital of Liaoning Province; Liaoning Tumor Hospital & InstituteRecruiting
-
Eileen ConnollyMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerUnited States
-
BioLite, Inc.Not yet recruiting
-
Yonsei UniversityActive, not recruitingBreast CancerKorea, Republic of
-
Washington University School of MedicineBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Illinois at ChicagoActive, not recruitingTriple Negative Breast CancerUnited States
-
amy tierstenNovartisActive, not recruiting
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of